Overview

Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions

Status:
Completed

Trial end date:
2006-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to demonstrate the relative bioavailability of Bicalutamide 50 mg tablet and Casodex following a 50 mg dose in healthy subjects under fed conditions.

Phase:

Phase 1

Details

Lead Sponsor:

Sandoz

Treatments:

Bicalutamide